Juan Jose Badimon

15PUBLICATIONS
24CO-AUTHORS
Molecular medicineEpidemiological modellingComparative economic systemsCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jun 04, 2025
Sotagliflozin: Two Birds with One Stone?

Juan Antonio Requena-Ibáñez, Kristine Mørk Kindberg, Carlos G Santos-Gallego

|Feb 05, 2025
Anaemia predicts iron homoeostasis dysregulation and modulates the response to empagliflozin in heart failure with reduced ejection fraction: the EMPATROPISM-FE trial.

Christiane E Angermann, Susanne Sehner, Louisa M S Gerhardt

|Sep 05, 2024
Does One Size Fits All?

Vanessa Roldan, Juan Jose Badimon

|Jul 03, 2024
Are Sodium-Glucose Cotransporter-2 Inhibitors the Cherry on Top of Cardio-Oncology Care?

Carlos A Gongora, Lili Zhang, Juan Lopez Mattei

|Jun 15, 2023
Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes.

Maeve Soto Pérez, Jorge Rodríguez-Capitán, Juan Antonio Requena-Ibáñez

|Apr 12, 2023
Cardioprotective Effect of Empagliflozin and Circulating Ketone Bodies During Acute Myocardial Infarction.

Carlos G Santos-Gallego, Juan Antonio Requena-Ibáñez, Belen Picatoste

Pageof 3

Frequent Collaborators

6 joint publications

Carlos G Santos-Gallego

3 joint publications

M Urooj Zafar

2 joint publications

Juan Antonio Requena-Ibanez

1 joint publications

Manuel Mayr